(Q44797073)

6 December 2017

title

Development of high affinity camptothecin-bombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells (English)

1 reference

6 December 2017

0 references

4

1 reference

6 December 2017

6

1 reference

6 December 2017

8

David H Coy

1 reference

6 December 2017

Terry W Moody

1

1 reference

6 December 2017

Samuel A Mantey

2

1 reference

6 December 2017

Tapas K Pradhan

3

1 reference

6 December 2017

Tomoo Nakagawa

5

1 reference

6 December 2017

Joseph Fuselier

7

1 reference

6 December 2017

Robert T Jensen

9

1 reference

6 December 2017

language of work or name

English

0 references

publication date

11 March 2004

1 reference

Journal of Biological Chemistry

6 December 2017

published in

1 reference

6 December 2017

volume

279

1 reference

6 December 2017

issue

22

1 reference

6 December 2017

page(s)

23580-23589

1 reference

Anticancer prodrugs for application in monotherapy: targeting hypoxia, tumor-associated enzymes, and receptors

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

An adjustable release rate linking strategy for cytotoxin-peptide conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Peptides as carrier for tumor diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Peptide receptors as molecular targets for cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Radiometallated receptor-avid peptide conjugates for specific in vivo targeting of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Neuropeptides as autocrine growth factors in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Melanotropin–daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

The Spectrum of Immunohistochemical Staining of Small-cell Lung Carcinoma in Specimens From Transbronchial and Open-lung Biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Hypothalamic hormones and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Detection of naturally expressed receptors for gastrin-releasing peptide and tachykinins using cyanine 3-labelled neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Mammalian bombesin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Identification of four amino acids in the gastrin-releasing peptide receptor that are required for high affinity agonist binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Molecular basis of the selectivity of gastrin-releasing peptide receptor for gastrin-releasing peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Direct observation of endocytosis of gastrin releasing peptide and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

Immunotoxicity of ethyl carbamate in female BALB/c mice: role of esterase and cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401938200

21 January 2018

Identifiers

DOI

10.1074/JBC.M401938200

1 reference

6 December 2017

1 reference